In a report released today, from Oppenheimer maintained a Hold rating on Amedisys. The company’s shares opened today at $99.23. Elevate Your Investing Strategy: Take advantage o ...

But a paper published in Nature Ageing might have found a lifestyle factor that could delay the onset of common chronic ...

New research shows that anti-inflammatory diets can slow the build-up of chronic diseases in older adults over 15 years.